Skip to main content
Equibles
PGEN logo

PGEN · Precigen, Inc.

Track PGEN — free

Use PGEN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.10 -0.04 (-0.56%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Customer concentration — key customers 49.9% of revenue

Key customers — 49.9% of revenue (the three months ended March 31, 2025)

“For the three months ended March 31, 2025, four customers accounted for 49.9% of total condensed consolidated revenues.”
View the 10-Q filed May 13, 2026
Market Cap
$2.54B
Shares
358.04M

PGEN metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.10
Market cap
$2.54B

Price action

19 metrics
Price change (1W)
+2.2%
Price change (30D)
+1.4%
Price change (3M)
+98.3%
Price change (6M)
+113.9%
Price change (YTD)
+69.9%
Price change (1Y)
+55.7%
Trailing year
Price change (5Y)
+15.6%
52-week high
$7.44
52-week low
$3.10
Change from 52-week high
-4.6%
Change from 52-week low
+129.0%
Annualized volatility
81.2%
Beta
1.5
RSI (14D)
57.8
Price vs SMA 50
+14.4%
Price vs SMA 200
+52.9%
Avg volume (3M)
5.14M
Relative volume
0.4
Average dollar volume
$30.50M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
358.04M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
29.7×
reciprocal yield 3.4%
P / book
58.3
reciprocal yield 1.7%
FCF yield
-4.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.2%

Historical valuation

8 metrics
P / E historical average (3Y)
9.3×
reciprocal yield 10.7%
P / E historical average (5Y)
9.3×
reciprocal yield 10.7%
EV / revenue historical average (3Y)
25.8×
reciprocal yield 3.9%
EV / revenue historical average (5Y)
13.7×
reciprocal yield 7.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
-46.1%
Trailing 12 months
Net margin
-2,588.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$39.50M
Net income (TTM)
−$157.71M
Trailing 12 months
Diluted EPS (TTM)
$-1.07
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-56.80

Growth

11 metrics
Revenue growth YoY
+6,322.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$85.72M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+39.6%
Year over year · more shares
Revenue CAGR (3Y)
-28.9%
Revenue CAGR (5Y)
-21.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-361.9%
Return on assets
-92.6%
Debt / equity
—
Current ratio
4.6
EBITDA (TTM)
−$35.36M
Free cash flow (TTM)
−$115.22M
Quick ratio
4.6
Interest coverage
-4.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$16.33M
Total assets
$170.30M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$114.17M
Capital expenditures (TTM)
$1.06M
R&D (TTM)
$32.29M
SG&A (TTM)
$84.93M
Stock compensation (TTM)
$13.14M
R&D / revenue
37.7%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
211
13F filer change QoQ
+5
Institutional ownership
40.6%

Short interest

3 metrics
Short interest
11.8%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.78M
Insider-sentiment score
41 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1356090 CUSIP 74017N105 13F (30d) 136 filings 136 filers Visit website Investor relations